In this clinical trial, 72% of caries lesions were arrested by silver diamine fluoride, with no harms. Contrary to the presumed antibacterial mechanism, lesion bacterial composition changed negligibly. This simple topical treatment is applicable to primary care practice and may reduce the burden of untreated tooth decay in the population.
INTRODUCTION
Dental and medical care providers are increasingly involved in early interventions to prevent tooth decay in young children.
[1] The main preventive service is the topical application of fluoride varnish every 3 to 6 months. The rationale is that fluoride treatments plus anticipatory guidance may prevent the onset of tooth decay at the time of greatest risk. This is important because tooth decay negatively impacts quality of life, [2, 3] particularly for children living in poverty, who have less access to dentists. Despite increased attention on young children, not all receive preventive treatments and large numbers still experience tooth decay. Primary care
providers have had little option other than invasive and costly specialist treatment in the hospital under general anesthesia. Silver ions are assumed to be primarily responsible for the antimicrobial action of silver diamine fluoride. Silver ions can lyse all tested bacteria, and denature enzymes that would breakdown collagenous dentin. [18, 19] Streptococcus mutans, a primary pathogen in dental caries, is less able to form a biofilm on teeth treated ex vivo. [20] Fluoride promotes deposition of fluoroapatite, which is more resistant to acidic degradation than normal tooth structure. [21] The purpose of this randomized controlled trial was to investigate the short-term effectiveness and safety of topically applied 38% silver diamine fluoride in arresting caries lesions in primary teeth.
In this context, there is interest in simple treatments

METHODS
Design
Double-blind randomized placebo-controlled superiority trial with two parallel groups.
Study Setting
Three Head Start programs (preschools) in the U.S. state of Oregon.
Participants
The children were healthy by medical history; 24 to 72 months of age; and had at least one untreated cavitated active caries lesion with dentin exposed based on the Nyvad criteria (level 3: "Enamel/dentin cavity easily visible with the naked eye; surface of cavity feels soft or leathery on gentle probing."). [22] The participant flow is outlined in Figure 1 . Recruitment began February 25, 2016 and the final child was evaluated on May 10, 2016.
Exclusion Criteria
Weight <15 kg; known sensitivity to silver or other heavy-metal ions; presence of any gingival or perioral ulceration or stomatitis; presence of a tooth abscess.
The study was conducted under IND 124808 from the Food and Drug Administration. The
Western Institutional Review Board approved the protocol and the informed consent of participants was obtained. A $50 gift card was provided after follow-up.
Treatment Conditions
Silver diamine fluoride (Advantage Arrest TM , Elevate Oral Care LLC., West Palm Beach, FL).
The test drug is a transparent blue-tinted solution containing 38 w/v% of silver (Ag) and 5.5 w/v% of fluorine (F). The placebo was non-fluoridated sterile water with a blue tint. The affected tooth surface was gently cleaned and dried with cotton gauze. The gingival tissue of the tooth was protected with petroleum jelly. An applicator was dipped into the agent and 3-4 mg applied to the lesion (1 drop treats 3 to 5 teeth). No rinse or special instructions were performed following application.
Plaque Sample collection
Before treatment and at the beginning of the follow-up examination, plaque samples were taken from up to 2 caries lesions and one unaffected tooth surface, selected sequentially from a list of tooth identifiers randomized for each patient, by rubbing a 2-mm diameter plastic applicator on the lesion surface for 4 seconds. The applicator was then placed in 250µL tryptic soy broth with 15% glycerol and 2% sucrose, inverted twice, and kept at -20˚C up to 2 months until moving to -80˚C to await processing.
Allocation
Participants were randomly assigned to groups with a 1:1 allocation using a computergenerated randomization schedule with stratification by Head Start program and randomly permuted blocks of sizes 2 and 4.
Blinding
The dental providers who applied the treatments, participants, and examiners were blinded.
Blinding was maintained by dispensing the test and comparator liquids from similar bottles.
The test and placebo bottles were assigned codes A, B, C or D with 2 codes for test and 2 codes for placebo. Four bottles were used to strengthen the blinding of treatment, and were otherwise identical. The biostatistician knew only which two labels were the same, but was blinded to which labels were the test or placebo conditions.
Primary Outcome
The primary outcome was caries lesion arrest. The hypothesis was that silver diamine fluoride is more effective than placebo in arresting caries lesions with dentin exposed in primary teeth.
A visual/tactile examination was performed before and 14 to 21 days after treatment to identify and assess lesions for caries activity. [22] The teeth were examined with artificial light but without magnification in the preschool setting after drying with cotton gauze. A change from a Nyvad lesion code 3 to 6 ("Enamel/dentin cavity easily visible with the naked eye; surface of cavity may be shiny and feels hard on probing with gentle pressure." [22] ) was considered a positive outcome: caries arrest. The criteria have been shown to be reliable and valid. [22] [23] [24] [25] The 14 to 21-day follow-up for outcome assessment was based on in vitro studies demonstrating silver diamine fluoride acts to arrest caries within this period. [26, 27] Six examiners were calibrated. The examiners reviewed the criteria and pictures showing the codes. Each independently examined 6 to 8 children with code 3 and code 6 lesions, including lesions treated with silver diamine fluoride. One investigator served as the index examiner. The observed agreement with the index examiner and 6 examiners ranged from 89.3% to 93.2%
and the kappa statistic ranged from 0.68 to 0.79.
Secondary outcome
The secondary outcome was to measure the change, if any, in relative abundance of microbial species or genus, assessed by metatranscriptomic (RNA) deep sequencing. The hypothesis was that caries-associated bacteria would decrease following treatment. We also hypothesized that prevalence of antibiotic and resistance genes would not change. RNA was used in proxy for vitality because many oral bacteria cannot be cultivated, and presence of RNA signifies production thereof by vital microbes within an hour beforehand. Plaque samples were collected from all participants. One participant in each study arm from each of the 3 study sites was selected from sequential lists of subject identification numbers by the biostatistician for the pilot analyses described here; treatment arm participants were selected from the subset for whom all studied lesions successfully arrested and placebo arm participants were selected from the subset from whom all studied lesions did not arrest. At the follow-up visit 14 to 21 days after treatment, a dental provider performed a visual examination to detect gingival or soft tissue stomatitis or ulcerative lesions. Lesions were characterized as mild or severe and either localized or generalized.
Harms
Analysis Plan
The primary outcome was the fraction of treated surfaces with arrested lesions at follow-up (code 6). The hypothesis was evaluated according to the intent-to-treat principle and based on all children who completed follow-up (97.0%). An exact two-sample permutation test was used to compare the mean fraction of arrested lesions between the two treatment conditions. [28] Bias-corrected bootstrap confidence intervals using 10,000 replications were also constructed for the mean fraction of arrested lesions by treatment condition and for the difference in mean fraction of arrested lesions between the 2 treatment conditions. [29, 30] Log-linear regression, implemented using generalized estimating equation (GEE) methods, was used as a confirmatory analysis, comparing the rate of arrested lesions between the 2 treatment conditions, which accounted for the number of treated surfaces and length of follow-up by including the product of these 2 quantities as an offset term in the regression analysis. [31] In addition, the proportion of children with 100% of caries arrested was compared between the 2 treatment conditions using Fisher's exact test, and exact 95% confidence intervals were constructed for the proportion by treatment condition and for the difference in proportions between the 2 treatment conditions. [32, 33] A two-sided 5% significance level was used for all statistical inference. Statistical analyses were performed using SAS, Version 4 (SAS Institute
Inc., Cary, NC, USA) and R, Version 3.3.0 (R Core Team, Vienna, Austria).
Sample Size
Based on a two-sample t test, for 80% power it was estimated 79 to 100 participants per group were required to demonstrate a difference of 0.40 to 0.45 SDs in the mean fraction of arrested caries. If there were no arrested caries in the control group and 25% in the silver diamine fluoride group, it was estimated this difference would correspond to a difference of 0.40 to 0.45
SDs. Due to a delay in initiating the study and the need to complete follow-up by the end of the school year, only 66 participants were enrolled. However, the observed difference in the mean fraction of arrested caries was much higher (2.4 SDs) than used in the sample size determination.
Metatranscriptomic sequencing library preparation
Total RNA was extracted by adding the applicator and 100 µL holding media to 400µL 
Sequencing read analysis
Following CASAVA quality filtering (Illumina, San Diego, CA, USA), human sequences (v38) were removed using the STAR alignment tool. [35] Low-quality sequences were removed with
PriceSeqFilter. [36] Redundant reads were removed using CD-HIT-DUP. [37] Low-complexity sequences (Lempel-Ziv-Welch ratio of less than 0.42) were removed. Illumina adapter and X174 control sequences were removed using BowTie2. [38] A random subset of 300,000
reads was searched against a repeat-masked [39] subversion of the NCBI nonredundant nucleotide (nt) database (version July 2015) using GSNAPL, [40] and processed with internal scripts. The subset was searched against the BacMet database[41] using RapSearch2 [42] to assess levels of metal-and antibiotic-resistance genes.
High quality sequencing reads were obtained in abundance (2.9±1.9*10^6 reads) for all but one sample (56,835 from the unaffected surface of participant 3058 at follow-up). 21.7±5.0% of filtered reads mapped to nt, which is typical for metatranscriptomic sequencing. The media negative control showed low background (937 reads), verifying the clinical source of reads for the other samples. The spiked positive control resulted in nearly all reads matching S. cerevisiae (89%) or fungal yeasts (3%), as expected.
Microbiology
Taxonomic and resistance gene counts were analyzed for significant changes using LME4 (R Core Team). Nested grouping was used to represent the experimental design of paired beforeafter samples and paired lesion-plaque samples from the same patients. The regression design was: ~treatment+time+treatment:time, where the ß coefficient for treatment:time was assessed for changes. False discovery rates were considered significant when the P value divided by the number of assessed taxa or genes (Bonferroni correction) were less than 0.01.
RESULTS
Sixty-six children were randomized. Thirty-six participants were randomly assigned to placebo, (Table 2) .
Outcomes
The mean fraction of teeth with all lesions arrested in the silver diamine fluoride group was 
Microbiology
Metagenomic sequencing analysis revealed an abundance of vital microbes in all lesions, as inferred by presence of RNA. Contrary to the initial hypothesis, the relative abundance of only a few species were significantly altered in caries lesions by the intervention (Figure 2) . No bacteria associated with caries changed significantly. Streptococcus mutans and Lactobacilli, the bacteria primarily associated with dental caries, were found in all samples except one unaffected surface before treatment, with no correspondence to treatment. All changes in relative abundance of species with a Bonferroni-adjusted probability of false discovery <0.01
were modest increases, not significant decreases as originally hypothesized. Low-level changes in many taxa were observed, but few were consistent. No significant changes in expression of antibiotic or metal resistance genes were observed.
Diversity analyses showed no significant differences (Supplemental Figure S1 ). Principal component analysis resulted in a highly-distributed explanation model (low attribution to any component), with some non-clustered outgrouping of samples in the silver diamine fluoride group after treatment (Supplemental Figure S2) .
Harms
Within 48 hours of treatment, staff successfully contacted 51 of the 66 (77%) parents by telephone. (Supplemental Table S1 ) The contact rates were 62.2% for the placebo group and 83.3% for the silver diamine fluoride group. Eight adverse events were reported by parents, 4
in each condition. Based on enrolled participants, the adverse event rate was 11.1% in the placebo group (exact 95% CI: 3.2 to 26.7%) and 13.3% in the silver diamine fluoride group (exact 95% CI: 3.7 to 30.7%). Based on all contacted participants, the adverse event rate was 15.4% in the placebo group (exact 95% CI: 4.3 to 34.9%) and 16.0% in silver diamine fluoride group (exact 95% CI: 4.5 to 36.1%). There were no statistically significant differences by treatment.
The type of adverse event, severity and relationship of the adverse event to the treatment condition are reported in Supplemental Table S2 . The majority of the adverse events were either diarrhea or stomach ache, mild in severity and all resolved within 2 days of reporting.
DISCUSSION
In 3 to 5-year-old children, 38% silver diamine fluoride was dramatically more effective than placebo clinically in arresting lesions after about two weeks and was safe. This study 
Harms
Adverse events occurring in the two days following application were similar between groups.
One child in the treatment group was described as having a non-sore, non-irritated spot at the corner of the mouth that "looked like a burn," which is a typical description of the silver precipitation that occurs upon contact with the skin, which resolved by the 2-week follow-up.
Discoloration was not considered a harm, as the Food and Drug Administration defines harm as "damage to health." No tooth pain was reported in any treatment group patients, despite deep lesions in some. No gingival or mucosal irritation was observed at follow-up in any patients.
Limitations
The caries arrest outcome in this study was evaluated much earlier than in other clinical trials of silver diamine fluoride to treat dental caries; the shortest follow-up in other studies is 6 months. The average caries arrest rate in 6 months in these studies is roughly 43%.[5,6,8] The comparatively high rate observed in this study may be because the blue coloring of the agent allows more complete application or because there is a greater initial response that fades with time without reapplication. A limitation of the microbiological analyses is that they measure the relative abundance of various species rather than absolute concentrations within a lesion;
previous observations suggest the quantity of microbes is dramatically reduced. Reactivation of lesions was observed in a 2-year study with only a single application.
[9] Indeed, higher rates of caries arrest at 6 months were observed when silver diamine fluoride was applied thrice in two weeks versus once.
[8] Monitoring of treated lesions to ensure arrest is indicated.
CONCLUSION
Consistent with the literature, topical 38% silver diamine fluoride arrests tooth decay and is effective for the short-term treatment of dental caries in pre-school age children. The effect is rapid and safe. The potential for microbial resistance appears low. Supplemental Tables   Table S1 . Completion of 24-48 follow-up and reported adverse events. Figure S1 . Various diversity analyses consistently assign no significant changes in microbial diversity following SDF treatment. A trend towards increased diversity is consistently observed. Pl: Placebo; SDF: Silver diamine fluoride. Figure S2 . Principal component analysis shows outgrouping of half the post-treatment SDF group by components 2 and 4, which suggests subtle but distinguishable changes from treatment. The highly distributed explanation model (low attribution to any component) indicates high levels of similarity, or highly complex differences, between all samples. PC: principal component; Pl: Placebo; SDF: Silver diamine fluoride. 
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